Law Commons^™

Keynote Address, Recent Fda Hct/P Guidance: Help Or Hindrance?, Mary Ann Chirba

Mary Ann Chirba

The Aca, The Supreme Court And The Race For The White House: Does Anyone Understand Health Care Finance And Delivery?, Mary Ann Chirba

Mary Ann Chirba

The Aca: Where Did It Come From And Where Is It Going?, Mary Ann Chirba

Mary Ann Chirba

No abstract provided.

King V. Burwell - The Supreme Court Upholds Federal Subsidies For State And Federal Health Insurance Exchanges, Mary Ann Chirba

Mary Ann Chirba

No abstract provided.

King V. Burwell: Reflections On The Long And Bumpy Road To Aca Implementation, Mary Ann Chirba

Mary Ann Chirba

No abstract provided.

Fda Regulation Of Adult Stem Cell Therapies As Used In Sports Medicine, Mary Ann Chirba, Berkly Sweetapple, Charles P. Hannon, John A. Anderson

Mary Ann Chirba

In sports medicine, adult stem cells are the subject of great interest. Several uses of stem cells are under investigation including cartilage repair, meniscal regeneration, anterior cruciate ligament reconstruction, and tendinopathy. Extensive clinical and basic science research is warranted as stem cell therapies become increasingly common in clinical practice. In the United States, the Food and Drug Administration (FDA) is responsible for regulating the use of stem cells through its “Human Cells, Tissues, and Cellular and Tissue-Based Products” regulations. This report provides a brief overview of FDA regulation of adult stem cells. Several common clinical case scenarios are then presented …

Regulatory Updates To Health Care Reform: Law And Practice, Mary Ann Chirba, Alice Noble, Michael Maddigan

Mary Ann Chirba

No abstract provided.